TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ARCT

Arcturus Therapeutics Holdings Inc

Healthcare · Biotechnology

14.70$ -8.4% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Arcturus Therapeutics Holdings Inc (ARCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 271 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARCT
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
22 72 52 52 44 82 476 393 450 429 344 271
22 52 51 51 42 74 468 379 403 387 306 241
2.2 17 2.3 25 37 71 463 370 392 292 237 231
22 51 50 49 37 71 463 370 392 292 237 231
0.1 0.3 3.6 0.5 4.5 2.2 2.1 3.4 2.8 32 4.0 5.6
-0.1 -0.5 1.5 0.0 0.0 -7.5
0.1 0.2 1.3 1.0 2.0 7.5 3.4 11 45
2.4 2.4 4.3 18 31 56 80 165 180 151 103 57
2.4 2.4 4.3 11 13 21 50 100 127 82 65 36
0.1 0.8 2.9 24 65 4.3 3.6 4.2
0.3 0.1 3.4 1.8 2.4 5.8 11 10 7.4 5.3 7.2 4.2
9.9 15 14 41
20 69 47 34 14 26 397 228 270 279 241 214
-52 -71 -96 -23 -45 -72 -144 -347 -338 -368 -449 -515
2.0 3.1 3.9 3.1 10 12 20 26 27 27 27 27

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?